Who
Gerard Ber
Director
Company insider
Files Form 4 as: Director, Lantheus Holdings; Director, Y-mAbs Therapeutics; Director, Progenics Pharmaceuticals.
In numbers
- Trades disclosed
- 38
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $1.6M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 12 Jun 2019
- Last trade
- 14 May 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 3 Jun 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $37K381 at $96.67 | filing |
| 14 May 2026filed 3 Jun 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $37K381 at $96.67 | filing |
| 14 May 2026filed 18 May 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —4,137 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —4,137 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,543 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,537 at $0.00 | filing |
| 9 May 2025filed 13 May 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $32K396 at $81.74 | filing |
| 12 Aug 2024filed 14 Aug 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $1.1M11,175 at $96.23 | filing |
| 12 Aug 2024filed 14 Aug 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $410K4,225 at $97.10 | filing |
| 12 Aug 2024filed 14 Aug 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $9,778100 at $97.78 | filing |
| 10 Jun 2024filed 11 Jun 2024 | Y-mAbs Therapeutics | SEC FORM 4 Sold | $8,664722 at $12.00 | filing |
| 13 May 2024filed 15 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $24K302 at $77.88 | filing |
| 9 May 2024filed 13 May 2024 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,853 at $0.00 | filing |
| 9 May 2024filed 13 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,635 at $0.00 | filing |
| 8 Jun 2023filed 9 Jun 2023 | Y-mAbs Therapeuticsoption or derivative | SEC FORM 4 Code A | —13,950 at $0.00 | filing |
| 8 Jun 2023filed 9 Jun 2023 | Y-mAbs Therapeutics | SEC FORM 4 Code A | —2,330 at $0.00 | filing |
| 11 May 2023filed 15 May 2023 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,798 at $0.00 | filing |
| 11 May 2023filed 15 May 2023 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,012 at $0.00 | filing |
| 8 May 2023filed 15 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $31K327 at $94.82 | filing |
| 15 Jul 2022filed 19 Jul 2022 | Y-mAbs Therapeuticsoption or derivative | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.